Canada markets closed

JCR Pharmaceuticals Co., Ltd. (4552.T)

Tokyo - Tokyo Delayed Price. Currency in JPY
Add to watchlist
607.000.00 (0.00%)
At close: 03:15PM JST
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2024-03-31
2023-03-31
2022-03-31
2021-03-31
2020-03-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
18,756,000
13,278,000
30,733,000
26,260,000
-
Other Short Term Investments
-
-
244,000
-
220,000
Total Cash
18,756,000
13,278,000
30,977,000
26,260,000
-
Net Receivables
14,934,000
11,137,000
15,585,000
8,183,000
-
Inventory
20,933,000
18,514,000
14,636,000
13,554,000
-
Other Current Assets
2,958,000
4,873,000
990,000
548,000
-
Total Current Assets
57,581,000
47,802,000
62,188,000
48,545,000
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
30,038,000
32,679,000
26,781,000
17,169,000
-
Net property, plant and equipment
30,040,000
32,681,000
26,782,000
17,172,000
-
Intangible Assets
3,496,000
3,652,000
2,960,000
3,232,000
-
Other long-term assets
365,000
362,000
326,000
296,000
-
Total non-current assets
44,642,000
47,133,000
34,944,000
25,236,000
-
Total Assets
102,226,000
94,937,000
97,134,000
73,784,000
-
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Current Debt
8,950,000
17,300,000
15,150,000
12,850,000
-
Accounts Payable
890,000
1,563,000
1,324,000
2,932,000
-
Other Current Liabilities
14,763,000
12,975,000
13,472,000
7,392,000
-
Total Current Liabilities
30,135,000
35,762,000
42,054,000
29,028,000
-
Non-current liabilities
Long Term Debt
14,350,000
5,500,000
2,950,000
5,250,000
-
Other long-term liabilities
284,000
244,000
96,000
93,000
-
Total non-current liabilities
15,618,000
6,763,000
3,994,000
6,203,000
-
Total Liabilities
45,753,000
42,525,000
46,048,000
35,231,000
-
Stockholders' Equity
Common Stock
9,061,000
9,061,000
9,061,000
9,061,000
-
Retained Earnings
37,278,000
34,273,000
33,241,000
20,904,000
-
Total stockholders' equity
56,176,000
52,161,000
50,881,000
38,379,000
-
Total liabilities and stockholders' equity
102,226,000
94,937,000
97,134,000
73,784,000
-